These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1290294)

  • 21. [Regulation of calcium liberation in sarcoplasmic reticulum and heart muscle cells].
    Callewaert G; Sipido KR
    Verh K Acad Geneeskd Belg; 1997; 59(5):401-34. PubMed ID: 9490926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcoplasmic reticular Ca2+ pump ATPase activity in congestive heart failure due to myocardial infarction.
    Afzal N; Dhalla NS
    Can J Cardiol; 1996 Oct; 12(10):1065-73. PubMed ID: 9191500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy.
    Schotten U; Koenigs B; Rueppel M; Schoendube F; Boknik P; Schmitz W; Hanrath P
    J Mol Cell Cardiol; 1999 Aug; 31(8):1483-94. PubMed ID: 10423346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New cardiotonic/inodilator agents: energetic aspects].
    Hasenfuss G
    Z Kardiol; 1992; 81 Suppl 4():57-63. PubMed ID: 1290307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced sarcoplasmic reticulum Ca(2+) load mediates impaired contractile reserve in right ventricular pressure overload.
    Quaile MP; Rossman EI; Berretta RM; Bratinov G; Kubo H; Houser SR; Margulies KB
    J Mol Cell Cardiol; 2007 Nov; 43(5):552-63. PubMed ID: 17931654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities of calcium cycling in the hypertrophied and failing heart.
    Houser SR; Piacentino V; Weisser J
    J Mol Cell Cardiol; 2000 Sep; 32(9):1595-607. PubMed ID: 10966823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency-dependent changes in contribution of SR Ca2+ to Ca2+ transients in failing human myocardium assessed with ryanodine.
    Schlotthauer K; Schattmann J; Bers DM; Maier LS; Schütt U; Minami K; Just H; Hasenfuss G; Pieske B
    J Mol Cell Cardiol; 1998 Jul; 30(7):1285-94. PubMed ID: 9710797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The contractile heart. Cellular and subcellular aspects].
    Larsen TH
    Tidsskr Nor Laegeforen; 1994 Dec; 114(30):3636-40. PubMed ID: 7825147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of cardiomyocyte dysfunction in heart failure following myocardial infarction in rats.
    Holt E; Tønnessen T; Lunde PK; Semb SO; Wasserstrom JA; Sejersted OM; Christensen G
    J Mol Cell Cardiol; 1998 Aug; 30(8):1581-93. PubMed ID: 9737944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in gene expression in terminal myocardial failure].
    Eschenhagen T; Mende U; Schmitz W; Scholz H
    Z Kardiol; 1992; 81 Suppl 4():33-40. PubMed ID: 1290304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [E-C coupling of the failing myocardium].
    Kihara Y
    Nihon Rinsho; 1993 May; 51(5):1210-6. PubMed ID: 8331788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congestive heart failure: role of altered myocardial cellular control.
    Katz AM
    N Engl J Med; 1975 Dec; 293(23):1184-91. PubMed ID: 171570
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathophysiological targets for beta-blocker therapy in congestive heart failure.
    Just H
    Eur Heart J; 1996 Apr; 17 Suppl B():2-7. PubMed ID: 8733064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular aspects of contractile dysfunction in heart failure.
    Mittmann C; Eschenhagen T; Scholz H
    Cardiovasc Res; 1998 Aug; 39(2):267-75. PubMed ID: 9798511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is contractility depressed in the failing human heart?
    Gwathmey JK; Liao R; Helm PA; Thaiyananthan G; Hajjar RJ
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):581-7. PubMed ID: 8547208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basic mechanisms of myocardial dysfunction: cellular pathophysiology of heart failure.
    Figueredo VM; Camacho SA
    Curr Opin Cardiol; 1994 May; 9(3):272-9. PubMed ID: 8049585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diastolic dysfunction and myocardial energetics.
    Pouleur H
    Eur Heart J; 1990 May; 11 Suppl C():30-4. PubMed ID: 2188840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subcellular basis of disorders of the contractile capacity of the heart in L-thyroxine-induced thyrotoxicosis].
    Karsanov NV; Melashvili NO; Khugashvili ZG; Mamulashvili LD; Azrumelashvili MI; Khaindrava GK; Kapanadze RV
    Kardiologiia; 1990 Feb; 30(2):81-7. PubMed ID: 2348627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excitation-contraction coupling in heart failure.
    Lakatta EG
    Hosp Pract (Off Ed); 1991 Jul; 26(7):85-8, 91-8. PubMed ID: 1677009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.